Inventor · disambiguated record
James Mcarthur
Also filed as: MCARTHUR JAMES · MCARTHUR JAMES G
17 granted patents·8 pending applications·411 citations·filing 1999–2024
94Inventor score
Files withCELL GENESYS INC7ADHERON THERAPEUTICS INC2CARDURION PHARMACEUTICALS INC2IMARA INC2MCARTHUR JAMES G2
Top patents by PatentIndex Score
25 records- 0196US7179903B2Liver specific transcriptional enhancerCELL GENESYS INC·Filed 2004·Granted Feb 20, 2007·89 cites·9 claims
- 0295US6808905B2Lentiviral vectors encoding clotting factors for gene therapyCELL GENESYS INC·Filed 2002·Granted Oct 26, 2004·64 cites·33 claims
- 0393US7745179B2Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using sameGBP IP LLC·Filed 2007·Granted Jun 29, 2010·53 cites·28 claims
- 0492US6733757B2Adeno-associated virus capsid immunologic determinantsFiled 2002·Granted May 11, 2004·53 cites·10 claims
- 0589US6521602B1Anti-neoplastic compositions and uses thereofGPC BIOTECH INC·Filed 2000·Granted Feb 18, 2003·22 cites·11 claims
- 0686US7217421B1Cancer-associated antigens and methods of their identification and useCELL GENESYS INC·Filed 2000·Granted May 15, 2007·25 cites·9 claims
- 0784US7972846B2Cadherin-11 antagonists and methods for the treatment of inflammatory joint disordersSYNOVEX CORP·Filed 2009·Granted Jul 5, 2011·8 cites·11 claims
- 0884US6498244B1Adeno-associated virus capsid immunologic determinantsCELL GENESYS INC·Filed 1999·Granted Dec 24, 2002·62 cites·6 claims
- 0981US8591888B2Cadherin-11 EC1 domain antagonists for treating inflammatory joint disordersMCARTHUR JAMES G·Filed 2009·Granted Nov 26, 2013·4 cites·23 claims
- 1077US7226606B2Cancer-associated antigens and methods of their identification and useCELL GENESYS INC·Filed 2005·Granted Jun 5, 2007·3 cites·18 claims
- 1173US8940300B2Humanized antibodies targeting the EC1 domain of Cadherin-11 and related compositions and methodsMCARTHUR JAMES G·Filed 2011·Granted Jan 27, 2015·2 cites·9 claims
- 1271US2025120974A1Pde9 inhibitors for treating sickle cell diseaseCARDURION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1367US6420345B1Methods and reagents for inhibiting angiogenesisCELL GENESYS INC·Filed 1999·Granted Jul 16, 2002·24 cites·21 claims
- 1463US12213975B2PDE9 inhibitors for treating sickle cell diseaseCARDURION PHARMACEUTICALS INC·Filed 2021·Granted Feb 4, 2025·0 cites·7 claims
- 1557US9315568B2Cadherin-11 EC1 domain antagonists for treating inflammatory joint disordersADHERON THERAPEUTICS INC·Filed 2013·Granted Apr 19, 2016·0 cites·17 claims
- 1656US7645587B2Cancer-associated antigens and methods of their identification and useBIOSANTE PHARMACEUTICALS INC·Filed 2007·Granted Jan 12, 2010·0 cites·6 claims
- 1754US10792339B2Methods and compositions for treating phenylketonuriaCHILDRENS NAT MEDICAL CT·Filed 2016·Granted Oct 6, 2020·0 cites·20 claims
- 1853US2021121537A1Methods and Compositions for Treating PhenylketonuriaKOBAYASHI DIONE T·Filed 2020·Application pending·0 cites
- 1952US2021085684A1Pde9 inhibitors for treatment of peripheral diseasesIMARA INC·Filed 2020·Application pending·0 cites
- 2049US2011045003A1Cadherin-11 antagonists and methods for the treatment of inflammatory joint disordersSYNOVEX CORP·Filed 2010·Application pending·0 cites
- 2147US2004071659A1Viral-mediated delivery and in vivo expression of polynucleotides encoding anti-angiogenic proteinsFiled 2002·Application pending·0 cites
- 2244US2006286116A1Methods and compositions for treating B cell cancerMORNINGSIDE VENTURE INVEST LTD·Filed 2006·Application pending·0 cites
- 2341US2019307754A1Pde9 inhibitors for treatment of peripheral diseasesIMARA INC·Filed 2017·Application pending·0 cites
- 2440US6413943B1Methods and reagents for inhibiting proliferation of smooth muscle cellsCELL GENESYS INC·Filed 1999·Granted Jul 2, 2002·2 cites·26 claims
- 2534US2015132305A1Humanized Antibodies Targeting the EC1 Domain of Cadherin-11 and Related Compositions and MethodsADHERON THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Mcarthur files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →